25th Apr 2014 08:44
LONDON (Alliance News) - Allergy Therapeutics PLC said Friday that Chief Executive Manuel Llobet and Finance Director Ian Postlewaite acquired shares at nil cost under the company's long term share incentive plan on Thursday, as follows:
Director | Number of provisional shares awarded | Date of distribution | Total provisional shares held under LTIPs |
Manuel Llobet | 845,000 | 24 April 2014 | 3,190,000 |
Ian Postlethwaite | 422,500 | 24 April 2014 | 1,595,000 |
Shares in the pharmaceutical company were trading at 18.90 pence Friday morning, down 0.5%.
By Henry Quintana
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Allergy Thera.